NewGenIvf Group (NewGenIvf Group) Debt-to-EBITDA : N/A (As of Jun. 2023)

View and export this data going back to 2024. Start your Free Trial

What is NewGenIvf Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

NewGenIvf Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.20 Mil. NewGenIvf Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.16 Mil. NewGenIvf Group's annualized EBITDA for the quarter that ended in Jun. 2023 was $0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for NewGenIvf Group's Debt-to-EBITDA or its related term are showing as below:

During the past 2 years, the highest Debt-to-EBITDA Ratio of NewGenIvf Group was 1.58. The lowest was 0.62. And the median was 1.10.

NIVF's Debt-to-EBITDA is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 2.555
* Ranked among companies with meaningful Debt-to-EBITDA only.

NewGenIvf Group Debt-to-EBITDA Historical Data

The historical data trend for NewGenIvf Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewGenIvf Group Debt-to-EBITDA Chart

NewGenIvf Group Annual Data

Trend

Dec21

Dec22

Debt-to-EBITDA

1.58

0.62

NewGenIvf Group Quarterly Data
	Dec21	Jun22	Dec22	Jun23
Debt-to-EBITDA	N/A	N/A	N/A	N/A

Competitive Comparison of NewGenIvf Group's Debt-to-EBITDA

For the Medical Care Facilities subindustry, NewGenIvf Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NewGenIvf Group's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where NewGenIvf Group's Debt-to-EBITDA falls into.

NewGenIvf Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

NewGenIvf Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.203	+	0.249)	/	0.726
	=	0.62

NewGenIvf Group's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.196	+	0.157)	/	0
	=	N/A

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2023) EBITDA data.

NewGenIvf Group (NAS:NIVF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

NewGenIvf Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of NewGenIvf Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

NewGenIvf Group (NewGenIvf Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NewGenIvf Group Ltd (NAS:NIVF) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sukhumvit 21 Road, Asoke, 36/39-36/40, 13th Floor, PS Tower, Khlong Toei Nuea Sub-district, Watthana District, Bangkok, THA, 10110

Website

https://www.newgenivf.com

NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.

NewGenIvf Group (NewGenIvf Group) Headlines

From GuruFocus

NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings

By Marketwired • 04-22-2024